Brief: China Resources Pharmaceutical Says 9-Mth China Resources Boya Bio-Pharmaceutical Rev RMB2.19 Bln
26/10/2023 02:32
Oct 26 (Reuters) - China Resources Pharmaceuticals Ltd
3320.HK :
* 9-MONTH CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP
REVENUE
RMB2.19 BILLION VERSUS RMB2.08 BILLION
* 9-MONTH CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP NET
PROFIT
RMB474.1 MILLION VERSUS RMB428.9 MILLION
Source text for Eikon: ID:nHKS9Q428H
Further company coverage: 300294.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million